Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Marvin R Natowicz

Biographic Data

ID7062876
NAMEMarvin R Natowicz
GIVEN NAMESMarvin R
FAMILY NAMENatowicz
SIGNATURENATOWICZ M R
AFFILIATIONSCleveland Clinic
ORCID0000-0002-3018-546X
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS10
AUTHOR COUNT3
EDITOR COUNT0
FIRST PUBLICATION YEAR1997
LATEST PUBLICATION YEAR2023
H-INDEX1
  • Metabolomic biomarkers in autism

    Open Access•Alan M Smith, Elizabeth L R Donley et al.•ARTICLE•Frontiers in Psychiatry•2023

    Autism Spectrum Disorder (ASD or autism) is a phenotypically and etiologically heterogeneous condition. Identifying biomarkers of clinically significant metabolic subtypes of autism could improve understanding of its underlying pathophysiology and potentially lead to more targeted interventions. We hypothesized that the application of metabolite-based biomarker techniques using decision thresholds derived from quantitative measurements could iden…

  • A picture is worth a thousand words

    Open Access•Briana C Prager, Sherri Broder et al.•ARTICLE•Frontiers in Public Health•2022

    Adults with intellectual or developmental disability (IDD) comprise 1–2% of the population worldwide. IDD is a significant risk factor for premature morbidity or mortality. This is likely due in part to preventable health conditions, which are modifiable with the intervention of direct care providers in areas including nutrition, promotion of an active lifestyle and effective identification of health or functional deterioration. Adults with IDD a…

  • Public participation in medical policy-making and the status of consumer autonomy

    E H Hiller, Elaine Hiller et al.•ARTICLE•American Journal of Public Health•1997•Cited by: 10•References: 23

    OBJECTIVES: State newborn-screening programs collectively administer the largest genetic-testing initiative in the United States. We sought to assess public involvement in formulating and implementing medical policy in this important area of genetic medicine. METHODS: We surveyed all state newborn-screening programs to ascertain the screening tests performed, the mechanisms and extent of public participation, parental access to information, and p…

  • Public participation in medical policy-making and the status of consumer autonomy

    E H Hiller, Elaine Hiller et al.•ARTICLE•American Journal of Public Health•1997•Cited by: 10•References: 23

    OBJECTIVES: State newborn-screening programs collectively administer the largest genetic-testing initiative in the United States. We sought to assess public involvement in formulating and implementing medical policy in this important area of genetic medicine. METHODS: We surveyed all state newborn-screening programs to ascertain the screening tests performed, the mechanisms and extent of public participation, parental access to information, and p…

  • Public participation in medical policy-making and the status of consumer autonomy

    E H Hiller, Elaine Hiller et al.•ARTICLE•American Journal of Public Health•1997•Cited by: 10•References: 23

    OBJECTIVES: State newborn-screening programs collectively administer the largest genetic-testing initiative in the United States. We sought to assess public involvement in formulating and implementing medical policy in this important area of genetic medicine. METHODS: We surveyed all state newborn-screening programs to ascertain the screening tests performed, the mechanisms and extent of public participation, parental access to information, and p…

  • A picture is worth a thousand words

    Open Access•Briana C Prager, Sherri Broder et al.•ARTICLE•Frontiers in Public Health•2022

    Adults with intellectual or developmental disability (IDD) comprise 1–2% of the population worldwide. IDD is a significant risk factor for premature morbidity or mortality. This is likely due in part to preventable health conditions, which are modifiable with the intervention of direct care providers in areas including nutrition, promotion of an active lifestyle and effective identification of health or functional deterioration. Adults with IDD a…

  • Metabolomic biomarkers in autism

    Open Access•Alan M Smith, Elizabeth L R Donley et al.•ARTICLE•Frontiers in Psychiatry•2023

    Autism Spectrum Disorder (ASD or autism) is a phenotypically and etiologically heterogeneous condition. Identifying biomarkers of clinically significant metabolic subtypes of autism could improve understanding of its underlying pathophysiology and potentially lead to more targeted interventions. We hypothesized that the application of metabolite-based biomarker techniques using decision thresholds derived from quantitative measurements could iden…

Medicine (3 works) · Nursing (2 works) · Population (2 works) · Psychiatry (2 works) · Public health (2 works) · Alternative medicine (1 works) · Autism (1 works) · Autism spectrum disorder (1 works) · Autism Spectrum Disorder Research (1 works) · Autonomy (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae